Ferinject compared with Venofer for iron deficiency anemia in pregnancy
Compares Ferinject and Venofer in pregnant women with iron deficiency anemia.
Key facts
- Who runs it
- Western Galilee Hospital-Nahariya
- Where
- Israel1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 200 people, planned
- Started
- 2 Nov 2023
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Venofer 200 MG Per 10 ML Injection
- Ferinject
- Record updated
- 11 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women past 24 weeks with low blood iron causing anemia. It compares two iron drips, Venofer and Ferinject.
- Age
- 18 Years to 50 Years
- Sex
- Women only
- Disease stage
- Pregnancy beyond 24 weeks. Iron deficiency anemia with Hb below 9, or below 9.5 if the anemia causes symptoms or there was heavy bleeding after an earlier birth.
- Earlier treatment
- No iron given into a vein (IV iron) in the last month.
- Biomarker or test result
- Hemoglobin (Hb) below 9 gr/dl, or below 9.5 with symptoms or a past heavy bleed after birth.
Main reasons for not taking part
- Allergy to one of the study drugs
- IV iron treatment in the last month
- Other conditions linked to anemia, such as thalassemia Major, kidney failure, or spherocytosis
- Pregnancy with twins
- Anemia not caused by low iron
This trial only enrols pregnant participants. The registry sentence this rests on: pregnancy>24 weeks of gestation anemia with Hb<9 anemia with Hb<9.5 if symptomatic anemia or previous postpartum hemorrhage
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- pregnancy>24 weeks of gestation anemia with Hb<9 anemia with Hb<9.5 if symptomatic anemia or previous postpartum hemorrhage
Who cannot take part
- Allergy to one of the study's drugs
- Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis
- IV iron treatment in the last month
- Twin pregnancy
- non iron deficiency anemia
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in Israel.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin <9 gr/dl , treated with venofer and women treated with ferinject.
The 2 groups in the trial
- venoferExisting treatment, for comparison
Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with venofer
Treatment: Venofer 200 MG Per 10 ML Injection
- FerinjectExisting treatment, for comparison
Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with ferinject
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)
- Plain-language title
- Ferinject compared with Venofer for iron deficiency anemia in pregnancyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06061393, who can take part
- Record updated
- 11 September 2026